These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids. Hübner M, Hochhaus G, Derendorf H. Immunol Allergy Clin North Am; 2005 Aug; 25(3):469-88. PubMed ID: 16054538 [Abstract] [Full Text] [Related]
6. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease. Donohue JF, Ohar JA. Proc Am Thorac Soc; 2004 Aug; 1(3):152-60. PubMed ID: 16113428 [Abstract] [Full Text] [Related]
7. Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems. Tayab ZR, Hochhaus G. Expert Opin Drug Deliv; 2005 May; 2(3):519-32. PubMed ID: 16296772 [Abstract] [Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide. Derendorf H. J Clin Pharmacol; 2007 Jun; 47(6):782-9. PubMed ID: 17412829 [Abstract] [Full Text] [Related]
9. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease. Johnson M. Proc Am Thorac Soc; 2004 Jun; 1(3):200-6. PubMed ID: 16113435 [Abstract] [Full Text] [Related]
10. [Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases]. Ieda Y, Nagasaka Y. Clin Calcium; 2007 Jun; 17(6):955-62. PubMed ID: 17548937 [Abstract] [Full Text] [Related]
11. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective. Rohatagi S, Appajosyula S, Derendorf H, Szefler S, Nave R, Zech K, Banerji D. J Clin Pharmacol; 2004 Jan; 44(1):37-47. PubMed ID: 14681340 [Abstract] [Full Text] [Related]
12. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease. Calverley PM. Proc Am Thorac Soc; 2004 Jan; 1(3):161-6. PubMed ID: 16113429 [Abstract] [Full Text] [Related]
13. A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease. Uings IJ, Farrow SN. Curr Opin Pharmacol; 2005 Jun; 5(3):221-6. PubMed ID: 15907906 [Abstract] [Full Text] [Related]
14. The role of corticosteroids in chronic obstructive pulmonary disease. Calverley PM. Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440 [Abstract] [Full Text] [Related]
15. Predicting Exposure After Oral Inhalation of the Selective Glucocorticoid Receptor Modulator, AZD5423, Based on Dose, Deposition Pattern, and Mechanistic Modeling of Pulmonary Disposition. Bäckman P, Tehler U, Olsson B. J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):108-117. PubMed ID: 27740878 [Abstract] [Full Text] [Related]